Skip to main content
Caplight Logo









Synbio Technologies

Synbio Technologies

Private
Monmouth Junction, New JerseyHealthcare & Life Scienceshttps://synbio-tech.com/

Last Round

Private Equity

Jan 5, 2023

Total Funding Raised

$3.66M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Synbio Technologies is a synthetic biology company that provides DNA synthesis, gene synthesis, and other molecular biology services and products for researchers.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

gene synthesissynthetic biologycontract research organizationCRObiofoundryDNA synthesisDNA printingprotein expressionantibody servicesDNA sequencinggene editingdrug discoveryoligo synthesissynbiomolecular biology servicesCRISPR servicespeptide synthesiscodon optimizationDNA data storage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synbio Technologies Comparables

Compare Synbio Technologies with similar companies based on industry and business-model similarity.

Synbio Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GenScript
85%
Biomatik Corporation
83%
Elegen
81%

Synbio Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJan 5, 2023
Private PlacementMar 5, 2019
Private PlacementJul 24, 2018
Private PlacementOct 9, 2017
Series BJul 14, 2016
Series A
Aug 28, 2014

Key People

Founding team and executive leadership

Ping Y.

CEO and Founder

Founding Team

Ping Yang

CEO

Executive Team

Synbio Technologies Investors

Notable investors and investment history

Synbio Technologies investors
InvestorRounds
Kaitai CapitalPrivate Placement, Series B
Co-Win VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 74% MoM.

  • Mar 5, 2019

    $8M round with Kaitai Capital participating.

Synbio Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synbio Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synbio Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersMonmouth Junction, New Jersey
Employee Range24
Year Founded2013
Last FundingJan 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?